Countries |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results)1 |
Number of HIV+ pregnant women receiving ARV prophylaxis |
Estimated infant HIV infections averted2 |
Angola |
40,800 |
400 |
100 |
Botswana3 |
NA |
NA |
NA |
Burundi |
95,400 |
900 |
300 |
Cambodia |
127,300 |
400 |
100 |
Cameroon |
72,800 |
5,300 |
1,600 |
China |
41,900 |
100 |
44 |
Côte d’Ivoire |
421,400 |
11,000 |
3,400 |
Democratic Republic of the Congo |
200,400 |
2,200 |
700 |
Dominican Republic |
44,900 |
400 |
100 |
Ethiopia |
1,126,000 |
15,100 |
4,700 |
Ghana |
37,700 |
600 |
200 |
Guyana |
13,200 |
26 |
8 |
Haiti |
193,500 |
4,800 |
1,500 |
India3 |
NA |
NA |
NA |
Indonesia3 |
NA |
NA |
NA |
Kenya |
1,174,100 |
60,400 |
19,800 |
Lesotho |
26,900 |
7,000 |
2,200 |
Malawi |
243,800 |
18,000 |
5,600 |
Mozambique |
836,100 |
87,600 |
26,500 |
Namibia |
56,400 |
7,200 |
2,200 |
Nigeria |
1,263,200 |
40,500 |
12,400 |
Russia3 |
NA |
NA |
NA |
Rwanda |
141,000 |
4,100 |
1,300 |
South Africa |
924,300 |
253,400 |
78,600 |
Sudan |
12,000 |
600 |
200 |
Swaziland |
26,400 |
9,900 |
3,000 |
Tanzania |
1,151,700 |
53,000 |
16,300 |
Thailand3 |
NA |
NA |
NA |
Uganda |
1,231,100 |
68,100 |
20,900 |
Ukraine3 |
NA |
NA |
NA |
Vietnam |
449,300 |
1,300 |
400 |
Zambia |
611,700 |
51,100 |
15,600 |
Zimbabwe |
448,800 |
49,300 |
15,000 |
Regions |
|
|
|
Caribbean Region3 |
NA |
NA |
NA |
Central America3 |
NA |
NA |
NA |
Central Asia3 |
NA |
NA |
NA |
Total4 |
11,012,100 |
752,726 |
232,752 |
Notes: |
All numbers greater than 100 have been rounded off to the nearest 100. |
Footnotes: |
1This indicator has two components: 1) the number of women with known positive HIV infection attending an ANC for a new pregnancy over the last reporting period; and 2) the number of women attending ANC, Labor and Delivery sites who were tested for HIV and received results (which is also captured under the testing and counseling results). The previous PMTCT indicator: “the number of pregnant women receiving PMTCT services” included only women who were counseled and tested and received their test results. For further information, refer to Indicator P1.1.D in the PEPFAR Next Generation Indicator Guidance Version 1.2 on http://www.pepfar.gov/guidance/index.htm. |
3“NA” refers to countries or regions where USG did not support PMTCT or PMTCT ARV prophylaxis programs. |
4Due to several country updates, the total results for “Number of HIV+ pregnant women receiving ARV prophylaxis” and “Estimated infant HIV infections averted” are slightly higher than the reported results in the PEPFAR Blueprint and the 2012 World AIDS Day FACT Sheet. All results still reflect accomplishments through September 20, 2012. |